-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
April 11 this year is the 25th World Parkinson's Day.
Parkinson's disease (Parkinson's disease, PD) is the second largest neurodegenerative disease in the world, with a high incidence in the elderly.
Faced with the high rate of missed diagnosis, high rate of misdiagnosis, late diagnosis, and insufficient standardized treatment of Parkinson’s disease in my country, in order to strengthen the management of Parkinson’s disease and achieve standardized early diagnosis and early treatment of Parkinson’s disease, it is reported that today, 6 Parkinson’s disease companies across the country The Center for Disease Diagnosis and Treatment and the China Parkinson's Disease Training Base were established.
"The establishment of the Parkinson's Disease Center is the general trend.
Uncover the mystery of Parkinson's disease
Uncover the mystery of Parkinson's diseaseParkinson's disease is a common neurological disease, which occurs mostly in middle-aged and elderly people.
Due to the diverse early symptoms of Parkinson's disease, misdiagnosis is more common, mainly divided into motor symptoms and non-motor symptoms.
"Some of the non-motor symptoms of Parkinson's disease patients actually appeared 5 to 10 years before the onset of motor symptoms.
Why do young people suffer from Parkinson's disease? Professor Wan Xinhua, chief physician of the Department of Neurology of Peking Union Medical College Hospital, explained, “The pathogenesis of Parkinson’s disease is not yet clear, and it is mainly related to aging, genetics and environmental factors.
Early diagnosis and early treatment, drugs and long-term management delay progress
Early diagnosis and early treatment, drugs and long-term management delay progressBoth the international Parkinson's disease treatment guidelines and the Chinese guidelines emphasize that the treatment of Parkinson's disease should have three major goals: control motor symptoms, prevent motor complications, and improve non-motor symptoms.
Professor Feng Tao, deputy director of the Neurology Center of Beijing Tiantan Hospital, Capital Medical University, said, “There is currently no cure for Parkinson’s disease.
Professor Feng Tao further introduced, "Parkinson's disease requires comprehensive treatment and long-term management.
Specialized disease center promotes standardized diagnosis and treatment to help realize individualized treatment
Specialized disease center promotes standardized diagnosis and treatment to help realize individualized treatmentWhen talking about the intelligent management of Parkinson’s disease diagnosis and treatment center, Professor Chen Biao, chief physician of the Department of Neurology, Xuanwu Hospital of Capital Medical University, said, “In recent years, Internet chronic disease management has provided a new diagnosis and treatment path for Parkinson’s disease.
It is reported that the first batch of four hospitals in Beijing will establish Parkinson’s disease diagnosis and treatment centers, which will be assessed through exercise, cognition, and mood scales, as well as substantive ultrasound, tremor analysis, eye movement analysis and other diagnostic and treatment methods.